DUBLIN--(BUSINESS WIRE)--The "China Pharmaceutical Sector Report 2017 4th Quarter" report has been added to ResearchAndMarkets.com's offering.
This report provides a complete and detailed analysis of the pharmaceutical sector for China. The author presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.
What this report allows you to do:
- Understand the key elements at play in the pharmaceutical sector in China
- Assess market for growth in the sector
- View key data on production and sales for the sector in China
- Crystallise the forces both driving and restraining this sector in China
- Build a complete perspective on sector trade, investment and employment
- Understand the competitive landscape and who the major players are
- View M&A activity and major deals
- Gain an understanding of the regulatory environment for the sector in China
- Build a clear picture of trends and issues for sub-sectors (western medicine, traditional Chinese medicine).
Key Topics Covered:
1. Executive Summary
- Sector in Numbers
- Sector Overview
- Sector Snapshot
- Driving Forces
- Restraining Forces
2. Sector in Focus
- Quarterly Update
- Quarterly Summary
- Sector Outlook
- Sector Highlights
- Main Sector Indicators
- Top M&A Deals
- M&A Activity
3. Competitive Landscape
- Highlights
- Top Pharmaceutical Enterprises
- Top Pharmaceutical Manufacturers
- Top Pharmaceutical Exporters
- To Listed Companies
4. Companies in Focus
- Shanghai Pharmaceuticals Holding Co Ltd
- Nanjing Pharmaceutical Co Ltd
- Huadong Medicine Co Ltd
- China Meheco Co Ltd
- Kangmei Pharmaceutical Co Ltd
5. Regulatory Environment
- Government Policy
- Healthcare Reform 2015
- Sector Reform 2015-2016
- Anti-Corruption Policies
6. Western Medicine
- Highlights
- Main Indicators by Segment
7. Traditional Chinese Medicine
- Highlights
-
Main Indicators by Segment
For more information about this report visit https://www.researchandmarkets.com/research/zftjnp/china?w=4
